Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoid Syndrome Diarrhea”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT03722511
What this trial is testing

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Who this might be right for
Neuroendocrine TumorsCarcinoid Tumor of GI SystemDiarrhea+1 more
Lowell Anthony, MD 10
Testing effectiveness (Phase 2)Study completedNCT05361668
What this trial is testing

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 36
Testing effectiveness (Phase 2)WithdrawnNCT04713202
What this trial is testing

Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl

Who this might be right for
Neuroendocrine TumorsCarcinoid SyndromeDiarrhea
Chandrikha Chandrasekhara
Large-scale testing (Phase 3)Looking for participantsNCT07087054
What this trial is testing

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 141
Large-scale testing (Phase 3)Study completedNCT00774930
What this trial is testing

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Ipsen 115
Testing effectiveness (Phase 2)Ended earlyNCT01886287
What this trial is testing

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Who this might be right for
Neuroendocrine Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 2
Not applicableStudy completedNCT01234168
What this trial is testing

Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Who this might be right for
Neuroendocrine TumorsCarcinoid Syndrome
Ipsen 340